Abstract:Molecular modeling and pharmacophore study has been performed on a series of 2-Substituted-1-naphthols derivatives with potent 5-lipoxygenase inhibitory activity. Structural features responsible for the activity of the compounds were characterized by using physicochemical, topological, and electrotopological descriptors, calculated from the Molecular Design Suite Software (V-life MDS™ 3.5). The relationship developed between biological activity and electrostatic, steric, hydrophobicity parameters was explored to generate combinatorial library with various substitution. This library can be explored for the synthesis and study of future potential anti-inflammatory agent. The requirements for the 5-lipoxygenase inhibitory activity are explored with 2D-QSAR, group based QSAR (G-QSAR), and k-nearest neighbour studies. The statistically significant 2D-QSAR model having r2 = 0.8502 and q2 = 0.8144 with pred_r2 = 0.8072 and the best group based QSAR (G-QSAR) model having r2 = 0.9137 and q2 = 0.7808 with pred_r2 = 0.8490 was developed by simulated annealing based partial least squares method. Further analysis using k-nearest neighbour 3D-QSAR technique identifies two models obtained by simulated annealing (SA) and genetic algorithm (GA)-based partial least squares methods leading to 5-lipoxygenase activity prediction. The best simulated annealing QSAR model showed q2 = 0.8547, r2 = 0.8963, and standard error = 0.3677. It was observed that steric properties predicted by k-nearest neighbour MFA contours can be related to 5-lipoxygenase activity. The predictive ability of the resultant model was evaluated using a test set molecules and the predicted r2 = 0.8162. The best pharmacophore model with hydrophobic, hydrogen bond donor (HBD), and aromatic features has root mean square deviation (RMSD) of 0.5746. The QSAR model suggests that electron-withdrawing character is favorable for the 5-lipoxygenase inhibitory activity. This suggests that electron-withdrawing groups like a chlorine or fluorine atoms at naphthol moiety are good for anti-inflammatory activity. In addition to the electron-withdrawing character, electron-donating groups, hydrophobic and hydrogen bond donor groups positively contribute to the 5-lipoxygenase inhibition. The results of 2D-QSAR, Group based QSAR, and k-nearest neighbour 3D-QSAR studies give detailed structural insights as well as highlights important binding features of these 2-Substituted-1-naphthols derivatives as anti-inflammatory agents which can provide guidance for the rational design of novel potent 5-lipoxygenase inhibitors.

Combined 3D-Qsar, Pharmacophore and Docking Studies on Benzene-Sulfonamide Derivatives As Potent 12-Lipoxygenase Inhibitors

Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase

Structure-based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining CoMFA 3D QSAR Modeling and Virtual Screening.

Probing N-substituted 4-(5-mercapto-4-ethyl-4H-1,2,4-triazol-3-yl)- N-phenylpiperdine-1-carboxamides as potent 15-LOX inhibitors supported with ADME, DFT calculations and molecular docking studies

Molecular modeling and pharmacophore approach for structural requirements of some 2-substituted-1-naphthols derivatives as potent 5-lipoxygenase inhibitors

Development of 3,5-Dinitrobenzoate-based 5-Lipoxygenase Inhibitors.

Indole Derivatives As Potent Inhibitors of 5-Lipoxygenase: Design, Synthesis, Biological Evaluation, and Molecular Modeling.

2-Arylbenzo[b]furan Derivatives As Potent Human Lipoxygenase Inhibitors

Single and multiple inhibitors of the biosynthesis of 5‐, 12‐, 15‐lipoxygenase products derived from cinnamyl‐3,4‐dihydroxy‐α‐cyanocinnamate: Synthesis and structure–activity relationship

Dynamic Modeling of Human 5-Lipoxygenase-inhibitor Interactions Helps to Discover Novel Inhibitors.

Investigating the Catalytic Site of Human 15-Lipoxygenase-1 via Marine Natural Products

Experimental investigation and molecular simulations of quinone related compounds as COX/LOX inhibitors

Synthesis, in vitro lipoxygenase inhibition, docking study and thermal stability analyses of novel indole derivatives

Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases

Development of Novel Pyrrole Derivatives and Their Cinnamic Hybrids as Dual COX-2/LOX Inhibitors

Identification of 1, 4-Dihydrothieno[3 ', 2 ':5, 6] Thiopyrano [4, 3-C]pyrazole Derivatives As Human 5-Lipo-oxygenase Inhibitors

Replacement of an Indole Scaffold Targeting Human 15-Lipoxygenase-1 Using Combinatorial Chemistry

5-LOX INHIBITORY POTENTIAL AND ANTIOXIDANT ACTIVITY OF NEW ISOXAZOLE DERIVATIVES

Dual COX‐2 and 15‐LOX inhibition study of novel 4‐arylidine‐2‐mercapto‐1‐phenyl‐1H‐imidazolidin‐5(4H)‐ones: Design, synthesis, docking, and anti‐inflammatory activity

Benzo[d]isothiazole 1,1-Dioxide Derivatives As Dual Functional Inhibitors of 5-Lipoxygenase and Microsomal Prostaglandin E(2) Synthase-1.

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives